Search

everythinglearnresearchcommunity

for

Search:↓

Women of child-bearing age with androgenic alopecia lose hair density, especially in certain areas, and their hair becomes thinner. They also lose more than twice as much hair as healthy women.

Women with PCOS and androgenic alopecia have different triglyceride metabolism compared to those without hair loss.

Oral and topical finasteride are effective and safe for treating female hair loss.

PRP can increase hair density in women with hair loss, but more research is needed.

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

No significant link was found between the studied genes and female hair loss in the Polish population.

Androgenetic alopecia in women may be improved by targeting oxidative stress, inflammation, and fibrosis.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

Female hair loss causes emotional distress and needs holistic treatment.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

Trichoscopy helps diagnose female hair loss easily.

Female pattern hair loss is different from male pattern hair loss and has unclear genetic causes.

TrichoScan is reliable for counting and measuring hair density but may not accurately assess hair types in women with hair loss.

The androgen receptor gene doesn't help identify women likely to have female pattern hair loss.

Androgen receptors significantly affect hair loss in women with androgenetic alopecia.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Women with alopecia often experience high levels of anxiety and depression, needing psychiatric help.

Women with AGA often face anxiety, depression, and low self-esteem; psychological support is important.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

Six new hair loss factors in men not linked to female hair loss.

Low-level light therapy may help hair regrowth, but more research is needed.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Women with AGA have higher lipid levels, increasing heart disease risk.

Women with hair loss have more androgen receptors in certain hair follicles.

Scarring hair loss found in female pattern; biopsy needed for diagnosis.

Traction alopecia is common and preventable, especially among Indian women.

Minoxidil and botulinum toxin are equally effective for treating female hair loss.

Microbial imbalances in hair follicles may contribute to hair loss, especially in women.

Higher bad cholesterol levels are linked to more severe female pattern hair loss.

Both minoxidil-spironolactone and minoxidil-finasteride treatments work for hair loss, but minoxidil-spironolactone is slightly more effective, especially in women.